» Articles » PMID: 8926285

Differential Secretion of TNF-alpha and IFN-gamma by Human Peripheral Blood-derived NK Subsets and Association with Functional Maturation

Overview
Journal J Clin Immunol
Publisher Springer
Date 1996 Jan 1
PMID 8926285
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer cells can be separated into three major subsets (free, binder, and killer) based on their ability to bind and kill sensitive target cells. The nonbinder, nonkiller free cells are the most immature and can be activated to become binders and killers. Natural killer (NK) cells synthesize and secrete several cytokines that are intimately involved in NK activation. This study investigated the secretion of tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) by purified NK cells and NK subsets following activation by various stimuli. K562 target cells stimulated secretion of both TNF-alpha and IFN-gamma by both the binder and the killer subsets but not by the free subset. IFN-alpha activated the secretion of IFN-gamma only, whereas IL-2 activated the secretion of both TNF-alpha and IFN-gamma by the binder and killer subsets and secretion was augmented by the addition of K562 to the cultures. Phorbol myristate acetate (PMA) and ionophore stimulated TNF-alpha and IFN-gamma secretion in both the binder and the killer subsets, though IFN-gamma secretion was more pronounced in the binder subset. Activation of TNF-alpha and IFN-gamma secretion was dependent on de novo protein synthesis. Analysis at the single-cell level demonstrated that the binder subset had the highest frequency of cells secreting IFN-gamma. These results demonstrate that both the binder and the killer subsets can be activated to secrete TNF-alpha and IFN-gamma, whereas the free NK subset secretes little or no TNF-alpha and IFN-gamma following activation. These data suggest that the ability of NK cells to secrete TNF-alpha and IFN-gamma following activation correlates with the functional stage of maturation of NK cells.

Citing Articles

Advancements in the Study of the Immune Molecule NKp46 in Immune System-related Diseases.

Qian S, Zhou Y, Jin Z, Li X, Tian Y, Chen F Clin Rev Allergy Immunol. 2024; 67(1-3):96-110.

PMID: 39612130 PMC: 11638288. DOI: 10.1007/s12016-024-09010-5.


miR-15a and miR-15b modulate natural killer and CD8T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma.

Pathania A, Prathipati P, Olwenyi O, Chava S, Smith O, Gupta S Mol Ther Oncolytics. 2022; 25:308-329.

PMID: 35663229 PMC: 9133764. DOI: 10.1016/j.omto.2022.03.010.


Engineered NK Cells Against Cancer and Their Potential Applications Beyond.

Karvouni M, Vidal-Manrique M, Lundqvist A, Alici E Front Immunol. 2022; 13:825979.

PMID: 35242135 PMC: 8887605. DOI: 10.3389/fimmu.2022.825979.


Phenotypic and Functional Plasticity of CXCR6 Peripheral Blood NK Cells.

Angelo L, Hogg G, Abeynaike S, Bimler L, Vargas-Hernandez A, Paust S Front Immunol. 2022; 12:810080.

PMID: 35173710 PMC: 8841448. DOI: 10.3389/fimmu.2021.810080.


Innate Lymphoid Cells and Natural Killer Cells in Bacterial Infections: Function, Dysregulation, and Therapeutic Targets.

Elemam N, Ramakrishnan R, Hundt J, Halwani R, Maghazachi A, Hamid Q Front Cell Infect Microbiol. 2021; 11:733564.

PMID: 34804991 PMC: 8602108. DOI: 10.3389/fcimb.2021.733564.


References
1.
Swisher S, Economou J, Holmes E, Golub S . TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function. Cell Immunol. 1990; 128(2):450-61. DOI: 10.1016/0008-8749(90)90040-x. View

2.
Sedgwick J, Holt P . A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods. 1983; 57(1-3):301-9. DOI: 10.1016/0022-1759(83)90091-1. View

3.
Ortaldo J . Regulation of natural killer activity. Cancer Metastasis Rev. 1987; 6(4):637-51. DOI: 10.1007/BF00047471. View

4.
Sedgwick J, Holt P . The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview. J Immunol Methods. 1986; 87(1):37-44. DOI: 10.1016/0022-1759(86)90341-8. View

5.
Nagler A, Lanier L, Cwirla S, Phillips J . Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol. 1989; 143(10):3183-91. View